Detalhe da pesquisa
1.
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Int J Cancer
; 152(2): 267-275, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005450
2.
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
Breast Cancer Res Treat
; 198(1): 67-74, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624321
3.
Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.
Intern Med J
; 52(10): 1707-1716, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002929
4.
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.
Int J Cancer
; 149(2): 409-419, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33729581
5.
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer.
Acta Oncol
; 60(9): 1106-1113, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34184594
6.
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
Breast Cancer Res Treat
; 184(1): 87-95, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779037
7.
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.
Future Oncol
; 14(26): 2725-2739, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30004261
8.
Children's and adolescents' understanding of their small ventricular septal defects.
Pediatr Int
; 54(6): 824-8, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23039794
9.
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities.
Cancers (Basel)
; 14(17)2022 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077668
10.
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
Clin Breast Cancer
; 22(7): e764-e772, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941066
11.
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
Clin Breast Cancer
; 22(8): 792-800, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151018
12.
Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry.
Clin Colorectal Cancer
; 17(3): e593-e599, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29958812
13.
Docetaxel in very elderly men with metastatic castration-resistant prostate cancer.
Prostate Int
; 3(2): 42-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26157766
14.
Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice.
Asia Pac J Clin Oncol
; 10(4): 361-7, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25131961